
IDEXX Laboratories, Inc.
IDXXNASDAQHealthcareMedical - Diagnostics & Research
Previous close
$556.93
+$11.07 · +2.03%
Pre-market
$555.99
−$0.94 · -0.17%
Aug 24, 7:00 AM ET
IDXX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
64
Undervalued
Momentum
42
Neutral
Sentiment
68
Bullish
Risk resilience
57
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteIDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Michael Erickson
- Listed since
- Jun 21, 1991
- Employees
- 11,000
Market position
Day range
Current $556.93
52-week range
Current $556.93
- Open
- $546.4
- Previous close
- $545.86
- Volume
- 485.78K
- 0.76× average
- Average volume
- 639.12K
- Average daily volume
- Market cap
- 43.93B USD
- Beta
- 1.54
- Market reference 1
- 50-day average
- $560
- -0.55% below average
- 200-day average
- $615.1
- -9.46% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 55.08B USD
- P/E (TTM)
- 39.11×
- P/B (TTM)
- 27.66×
- P/S (TTM)
- 9.65×
- EV / EBITDA
- 37.5×
- Earnings yield
- 1.96%
- Free cash flow yield
- 1.94%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 62.45%
- Operating margin
- 32.03%
- Net margin
- 25.03%
- Return on equity
- 65.99%
- Return on assets
- 31.62%
- Return on invested capital
- 40.27%
Financial health
- Debt / equity
- 0.68×
- Current ratio
- 1.17×
Earnings
- Latest fiscal-year EPS
- 13.08
- FY2025 · +22.59% year over year
- Latest fiscal-year revenue
- 4.3B USD
- FY2025 · +10.42% year over year
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
IDXX news
IDXX peers
ETFs holding IDXX
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.4B0.06%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO1.16B0.07%1.7T USD0.03%$703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO954.44M0.42%224.7B USD0.03%$82.97+0.53%
Invesco QQQ Trust, Series 1QQQ926.95M0.19%485.41B USD0.18%$713.44+0.35%
iShares Core S&P 500 ETFIVV580.45M0.07%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY535.69M0.07%817.87B USD0.09%$765.72+0.41%
Vanguard Morningstar Growth ETFVUG523.07M0.14%372B USD0.03%$87.50+0.38%
Vanguard Morningstar Mid-Cap Growth ETFVOT337.22M1.00%33.5B USD0.05%$305.46+0.79%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.4B
- Weight
- 0.06%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 1.16B
- Weight
- 0.07%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 954.44M
- Weight
- 0.42%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.97+0.53%
Invesco QQQ Trust, Series 1QQQ- Market value
- 926.95M
- Weight
- 0.19%
- AUM
- 485.41B USD
- Expense ratio
- 0.18%
- Price / 1D
- $713.44+0.35%
iShares Core S&P 500 ETFIVV- Market value
- 580.45M
- Weight
- 0.07%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 535.69M
- Weight
- 0.07%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Vanguard Morningstar Growth ETFVUG- Market value
- 523.07M
- Weight
- 0.14%
- AUM
- 372B USD
- Expense ratio
- 0.03%
- Price / 1D
- $87.50+0.38%
Vanguard Morningstar Mid-Cap Growth ETFVOT- Market value
- 337.22M
- Weight
- 1.00%
- AUM
- 33.5B USD
- Expense ratio
- 0.05%
- Price / 1D
- $305.46+0.79%
Continue in GoAI
Research IDXXresearch.disclaimer











